Mallinckrodt shares slide on whistleblower lawsuit involving its best-selling drug
April 12, 2018 at 14:21 PM EDT
The lawsuit claims Mallinckrodt continued to raise the price of Acthar despite knowing what was in it.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.